A citation-based method for searching scientific literature

N A Singh, C Charlier, D Stauffer, B R DuPont, R J Leach, R Melis, G M Ronen, I Bjerre, T Quattlebaum, J V Murphy, M L McHarg, D Gagnon, T O Rosales, A Peiffer, V E Anderson, M Leppert. Nat Genet 1998
Times Cited: 871



Francesco Miceli, Maria Virginia Soldovieri, Paolo Ambrosino, Vincenzo Barrese, Michele Migliore, Maria Roberta Cilio, Maurizio Taglialatela. Proc Natl Acad Sci U S A 2013
Times Cited: 106




List of shared articles



Times cited

Clinical characteristics of KCNQ2 encephalopathy.
Hyo Jeong Kim, Donghwa Yang, Se Hee Kim, Dongju Won, Heung Dong Kim, Joon Soo Lee, Jong Rak Choi, Seung-Tae Lee, Hoon-Chul Kang. Brain Dev 2021
2

In Silico Predictions of KCNQ Variant Pathogenicity in Epilepsy.
David M Ritter, Paul S Horn, Katherine D Holland. Pediatr Neurol 2021
0


Venom-derived modulators of epilepsy-related ion channels.
Chun Yuen Chow, Nathan Absalom, Kimberley Biggs, Glenn F King, Linlin Ma. Biochem Pharmacol 2020
1

Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction.
Piera Nappi, Francesco Miceli, Maria Virginia Soldovieri, Paolo Ambrosino, Vincenzo Barrese, Maurizio Taglialatela. Pflugers Arch 2020
8

KCNQs: Ligand- and Voltage-Gated Potassium Channels.
Geoffrey W Abbott. Front Physiol 2020
9


Two KCNQ2 Encephalopathy Variants in the Calmodulin-Binding Helix A Exhibit Dominant-Negative Effects and Altered PIP2 Interaction.
Baouyen Tran, Zhi-Gang Ji, Mingxuan Xu, Tammy N Tsuchida, Edward C Cooper. Front Physiol 2020
0

The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our Understanding.
Nina Dirkx, Francesco Miceli, Maurizio Taglialatela, Sarah Weckhuysen. Front Physiol 2020
2


4

A de novo KCNQ2 Gene Mutation Associated With Non-familial Early Onset Seizures: Case Report and Revision of Literature Data.
Gianluigi Laccetta, Simona Fiori, Matteo Giampietri, Annarita Ferrari, Valentina Cetica, Manuela Bernardini, Francesca Chesi, Sara Mazzotti, Elena Parrini, Massimiliano Ciantelli,[...]. Front Pediatr 2019
0

KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines.
Rían W Manville, Jennifer van der Horst, Kaitlyn E Redford, Benjamin B Katz, Thomas A Jepps, Geoffrey W Abbott. Proc Natl Acad Sci U S A 2019
13

Autism and developmental disability caused by KCNQ3 gain-of-function variants.
Tristan T Sands, Francesco Miceli, Gaetan Lesca, Anita E Beck, Lynette G Sadleir, Daniel K Arrington, Bitten Schönewolf-Greulich, Sébastien Moutton, Anna Lauritano, Piera Nappi,[...]. Ann Neurol 2019
22

Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features.
Maria Virginia Soldovieri, Paolo Ambrosino, Ilaria Mosca, Francesco Miceli, Cristina Franco, Lorella Maria Teresa Canzoniero, Beth Kline-Fath, Edward C Cooper, Charu Venkatesan, Maurizio Taglialatela. Int J Mol Sci 2019
8

Genetics of neonatal-onset epilepsies.
Marie-Coralie Cornet, Maria Roberta Cilio. Handb Clin Neurol 2019
9

Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
Ayako Goto, Atsushi Ishii, Mami Shibata, Yukiko Ihara, Edward C Cooper, Shinichi Hirose. Epilepsia 2019
22

Neural stem cells and epilepsy: functional roles and disease-in-a-dish models.
Drew M Thodeson, Rebecca Brulet, Jenny Hsieh. Cell Tissue Res 2018
13

KCNQ-Encoded Potassium Channels as Therapeutic Targets.
Vincenzo Barrese, Jennifer B Stott, Iain A Greenwood. Annu Rev Pharmacol Toxicol 2018
45

Genetics update: Monogenetics, polygene disorders and the quest for modifying genes.
Joseph D Symonds, Sameer M Zuberi. Neuropharmacology 2018
7